Ledger.Open graph →
SEC Form D · filed October 29, 2021

RedShift BioAnalytics, Inc

Offering
$20.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Other Technology
Location
BURLINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

William Cadogan · Burlington, MADirectorBryson Hollimon · Burlington, MADirectorFrank Smith · Burlington, MADirectorCatherine A. Cawthon · Dublin, OHDirectorDavid W. Nassif · San Ramon, CADirectorStephen W. Farr · San Ramon, CADirectorCharles Purtell · Burlington, MADirectorJulien Bradley · Burlington, MAExec · DirectorAmol Chaubal · Marlborough, MADirectorKeith W. Bank · San Ramon, CADirectorJoshua Pierce · San Francisco, CADirectorMark A. Salomon · MIAMI BEACH, FLDirectorCharles Purtell · Burlington, MADirectorJulien Bradley · Burlington, MAExec · DirectorAmol Chaubal · Burlington, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗